Poland appeals Belgian court ruling over disputed Covid-19 vaccine debt
Warsaw challenges order to pay €1.3 billion for declined Pfizer-BioNTech doses under EU procurement deal.
Auf einen Blick
Poland has appealed a Belgian court ruling ordering it to pay roughly €1.3 billion for declined Covid-19 vaccine doses from Pfizer and BioNTech, stemming from controversial EU procurement contracts.
KI-generierte Zusammenfassung
Warum es wichtig ist
Poland stopped accepting vaccine deliveries citing force majeure, leading Pfizer to sue in 2023.
Poland has appealed a Belgian court ruling ordering it to pay for millions of Covid-19 vaccine doses it declined to accept under a controversial EU vaccine purchase deal.
The case stems from multibillion-euro contracts for Covid shots negotiated by European Commission President Ursula von der Leyen with manufacturers Pfizer and BioNTech during the pandemic. The agreements later became the focus of the so-called ‘Pfizergate’ scandal.
In a statement released on Monday, the Polish Health Ministry said the government had appealed the judgment and requested that its enforcement be suspended pending the court’s review. It argued that the lower court had failed to consider all the “relevant factual and legal circumstances” but did not disclose further details.
Pfizer sued Poland in 2023 after Warsaw stopped accepting deliveries, arguing that falling demand, an oversupply of vaccines and the economic impact of the Ukraine conflict amounted to force majeure. In April, the Brussels court ruled that Warsaw must accept roughly 64 million doses and pay about €1.3 billion ($1.5 billion), in addition to interest and legal costs.
Pfizer defended the ruling, telling Politico it reflected “the importance of the contractual obligations that underpinned a successful European pandemic response” and that the company had shown “significant flexibility” toward member states before pursuing legal enforcement.
Von der Leyen has faced scrutiny over her role in the vaccine deals, with opponents accusing her of concealing details of negotiations with Pfizer and AstraZeneca. She has come under particular criticism for refusing to disclose or preserve text messages she reportedly exchanged with Pfizer CEO Albert Bourla during the talks. The controversy prompted a no-confidence motion in the European Parliament last year, which she survived.
Worauf zu achten ist
KI-Ausblick — Möglichkeiten, keine Fakten
Court reviews Poland's request to suspend enforcement
Wahrscheinlich · Innerhalb von Wochen
Offene Fragen
- Will the Belgian court suspend the judgment enforcement?
- What specific legal circumstances did Poland argue were overlooked?




